Column Group Opportunity III, LP

CIK 0001931825

10% Owner

Filings

Latest Feb 26, 2026

Issuers covered

Showing

23 of 23

Page 1

Track record

43 of 53 open-market trades scored (81% price coverage) - 10 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	43	56%	+6.7%	+2.8%	+78.3%	-25.3%
90 days	43	56%	+21.1%	+21.4%	+183.5%	-47.1%
180 days	16	94%	+60.4%	+28.8%	+153.0%	-51.9%
365 days	10	90%	+77.3%	+82.9%	+162.7%	-83.3%

Issuers

Companies where Column Group Opportunity III, LP has filed

Ticker	Issuer	Filings	Last filed
TNYA	Tenaya Therapeutics, Inc.	9	Feb 26, 2026
NGM	Ngm Biopharmaceuticals Inc	7	Apr 8, 2024
SRZN	Surrozen, Inc./De	6	Jan 20, 2026
EIKN	Eikon Therapeutics, Inc.	1	Feb 9, 2026

All filings

23 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 26, 2026	TNYATenaya Therapeutics, Inc.	SSale	1,862,545	$0.5624	$1,047,495
Feb 24, 2026	TNYATenaya Therapeutics, Inc.	SSale	277,769	$0.6149	$170,800
Feb 12, 2026	TNYATenaya Therapeutics, Inc.	SSale	2,151,458	$0.6808	$1,464,713
Feb 9, 2026	EIKNEikon Therapeutics, Inc.	PPurchase	1,437,323	$18.00	$25,871,814
Jan 20, 2026	SRZNSurrozen, Inc./De	PPurchase	9,568	$19.5999	$187,532
Jan 15, 2026	SRZNSurrozen, Inc./De	PPurchase	6,609	$19.8041	$130,885
Jan 8, 2026	SRZNSurrozen, Inc./De	PPurchase	8,003	$19.8872	$159,157
Dec 8, 2025	SRZNSurrozen, Inc./De	PPurchase	16,381	$19.5409	$320,099
Nov 17, 2025	SRZNSurrozen, Inc./De	PPurchase	167,307	$12.65	$2,116,434
Mar 28, 2025	SRZNSurrozen, Inc./De	PPurchase	365,769	$11.60	$4,242,920
Mar 7, 2025	TNYATenaya Therapeutics, Inc.	PPurchase	35,714,284	$0.70	$24,999,999
Apr 8, 2024	NGMNgm Biopharmaceuticals Inc	DDisposition	949,862	-	-
Feb 14, 2024	TNYATenaya Therapeutics, Inc.	PPurchase	2,222,222	$4.50	$9,999,999
Nov 17, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	16,791	$0.7075	$11,880
Mar 14, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	6,779	$2.5956	$17,596
Feb 10, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	1,500,000	$2.60	$3,900,000
Feb 1, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	176,730	$4.9986	$883,403
Jan 25, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	9,900	$4.9994	$49,494
Jan 23, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	37,639	$4.9976	$188,105
Jan 23, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	69,739	$2.4979	$174,201
Jan 19, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	135,688	$2.5163	$341,432
Jan 17, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	5,378	$4.9466	$26,603
Jan 12, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	209,000	$4.76	$994,840

Showing 1-23 of 23

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value